|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.1710 - 0.2171|
|52 Week Range||0.1400 - 0.9890|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||6.95|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Is pleased to provide an update on the Company’s psilocybin pharmaceutical development programs. The ...
Announced that the U.S. Food and Drug Administration has approved the Company’s Investigational New ...
Announced that its wholly-owned subsidiary, PharmaTher has entered into an exclusive license agreement ...